Akeso doses first patient in Phase III Ivonescimab small cell lung cancer trial

Polymer Factory-led study advances nanocarrier-based drug delivery for aggressive cancers

RemeGen receives FDA approval to advance RC148 into Phase II trials for solid tumours

K36 Therapeutics' KTX-2001 IND application cleared by US FDA; company collaborates with Bayer for darolutamide supply

Spinogenix reports positive first cohort results from Phase 2a trial in Alzheimer's disease

Sebela Pharmaceuticals completes tegoprazan Phase 3 TRIUMpH programme in GERD with positive results

Avobis Bio seeks RMAT designation after primary analysis of clinical trial in Crohn's perianal fistulas

CorMedix to acquire Melinta Therapeutics in USD300m deal to expand infectious disease portfolio

Jazz Pharmaceuticals' Modeyso approved by US FDA for H3 K27M-mutant diffuse midline glioma treatment

Sanofi completes USD470m acquisition of Vigil Neuroscience

Sanyou Bio wins 'Best Customer Satisfaction CRO Award'

Kowa begins Phase 3 safety trial of Nicox's NCX 470 in Japan, triggering EUR2m milestone

MetaVia collaborates with Syntekabio to explore AI-driven indications for DA-1241

Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial

US FDA approves Innovent's IND application for IBI3032 oral GLP-1R agonist